These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 4645129

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The effect of luteectomy-induced progesterone-withdrawal on the oxytocin and prostaglandin response of the first trimester pregnant human uterus.
    Csapo AI, Pulkkinen MO, Kaihola HL.
    Prostaglandins; 1973 Sep; 4(3):421-9. PubMed ID: 4783575
    [Abstract] [Full Text] [Related]

  • 23. Induction of abortion in early first trimester human pregnancy using epostane.
    Webster MA, Gillmer MD.
    Br J Obstet Gynaecol; 1989 Mar; 96(3):340-5. PubMed ID: 2713292
    [Abstract] [Full Text] [Related]

  • 24. Intrauterine instillation of prostaglandin F2ALPHA IN EARLY PREGNANCY.
    Jones JR, Gentile GP, Kemmann EK, Soriero AA.
    Prostaglandins; 1975 Jun; 9(6):881-92. PubMed ID: 1162090
    [Abstract] [Full Text] [Related]

  • 25. The abortifacient action of the extraovular "prostaglandin impact" during the first half of human pregnancy.
    Enkola K.
    Prostaglandins; 1974 Jan 10; 5(1):115-21. PubMed ID: 4816714
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Massive initial prostaglandin impact in postconceptional therapy.
    Csapo AI, Kivikoski A, Wiest WG.
    Prostaglandins; 1972 Aug 10; 2(2):125-34. PubMed ID: 4653230
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The efficacy and acceptability of the "prostaglandin impact" in inducing complete abortion during the second week after the missed menstrual period.
    Csapo AI, Mocsary P, Nagy T, Kaihola HL.
    Prostaglandins; 1973 Feb 10; 3(2):125-39. PubMed ID: 4729565
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Prostaglandin-oxytocin enhancement.
    Seppälä M, Vara P.
    Br Med J; 1972 Mar 18; 1(5802):747. PubMed ID: 5015335
    [Abstract] [Full Text] [Related]

  • 34. Intravenous prostaglandin F 2 for therapeutic abortion.
    Kirshen EJ, Naftolin F, Ryan KJ.
    Am J Obstet Gynecol; 1972 Jun 01; 113(3):340-4. PubMed ID: 4637024
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
    Borten M, DiLeo LA, Friedman EA.
    Am J Obstet Gynecol; 1984 Nov 01; 150(5 Pt 1):561-5. PubMed ID: 6496588
    [Abstract] [Full Text] [Related]

  • 37. Prostaglandins and abortion. I. intramuscular administration of 15-methyl prostaglandin F2alpha for induction of abortion in weeks 10 to 20 of pregnancy. World Health Organization Task Force on the Use of Prostaglandins for the Regulation of Fertility.
    Am J Obstet Gynecol; 1977 Nov 15; 129(6):593-6. PubMed ID: 920759
    [Abstract] [Full Text] [Related]

  • 38. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
    Bolognese RJ, Corson SL.
    Fertil Steril; 1975 Jul 15; 26(7):695-9. PubMed ID: 1149900
    [Abstract] [Full Text] [Related]

  • 39. [New results of the clinicopharmacological study on Enzaprost-F (PGF2 alpha) cervical tablets (CHINOIN)].
    Farkas M.
    Acta Pharm Hung; 1991 Jan 15; 61(1):9-22. PubMed ID: 1872192
    [Abstract] [Full Text] [Related]

  • 40. Intravenous prostaglandin F2 for therapeutic abortion: the efficacy and tolerance of three dosage schedules.
    Brenner WE.
    Am J Obstet Gynecol; 1972 Aug 15; 113(8):1037-45. PubMed ID: 4635173
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.